Table 3.
Multivariant survival analysis of various factors in patients with PDAC
| Characteristic | SE | HR | 95%CI | P value |
|---|---|---|---|---|
| Age | 0.242 | 0.987 | 0.614-1.587 | 0.958 |
| Gender | 0.281 | 1.42 | 0.818-2.465 | 0.213 |
| Lymph node metastasis | 0.357 | 1.342 | 0.667-2.699 | 0.41 |
| Distantmetastasis | 0.6 | 0.68 | 0.209-2.204 | 0.52 |
| Tumor Stage | 0.415 | 0.32 | 0.142-0.722 | 0.006* |
| Tumor size | 0.289 | 3.07 | 1.743-5.407 | <0.001* |
| Differentiation | 0.406 | 0.344 | 0.155-0.762 | 0.009* |
| DEK | 0.317 | 0.379 | 0.204-0.706 | 0.002* |
| CA199 | 0.297 | 0.538 | 0.301-0.962 | 0.037* |
* P < 0.05